Cite
APA Citation
Hellmann, M., Rizvi, N., Gettinger, S., Goldman, J., Chow, L., Juergens, R., Borghaei, H., Brahmer, J., Shen, Y., Harbison, C., Nathan, F., Ready, N., & Antonia, S. (n.d.). 3097 Safety and efficacy of first-line nivolumab (NIVO) and ipilimumab (IPI) in non-small cell lung cancer (NSCLC). European journal of cancer, 51, S632–S633. http://access.bl.uk/ark:/81055/vdc_100030628321.0x000009